LPNT has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
LPNT has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companyยs financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.05 |
LPNT's Cash to Debt is ranked lower than
77% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.32 vs. LPNT: 0.05 ) |
LPNT'
s 10-Year Cash to Debt Range
Min: 0.01 Max: 0.38 Current: 0.05 |
| Equity to Asset | 0.075 |
LPNT's Equity to Asset is ranked lower than
64% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.26 vs. LPNT: 0.075 ) |
LPNT'
s 10-Year Equity to Asset Range
Min: -0.05 Max: 0.45 Current: 0.08 |
| Interest Coverage | 16 |
LPNT's Interest Coverage is ranked lower than
79% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 7.80 vs. LPNT: 16 ) |
LPNT'
s 10-Year Interest Coverage Range
Min: 2 Max: 16 Current: 16 |
| F-Score: 7 |
|
| Z-Score: 1.92 |
|
| M-Score: -3.26 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ยย3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 34.50 |
LPNT's Operating margin (%) is ranked lower than
71% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 7.30 vs. LPNT: 34.50 ) |
LPNT'
s 10-Year Operating margin (%) Range
Min: 8.4 Max: 34.5 Current: 34.5 |
| Net-margin (%) | 3.3 |
LPNT's Net-margin (%) is ranked lower than
58% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 3.85 vs. LPNT: 3.3 ) |
LPNT'
s 10-Year Net-margin (%) Range
Min: -1.4 Max: 8.6 Current: 3.3 |
| ROE (%) | 7.4 |
LPNT's ROE (%) is ranked lower than
67% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 11.20 vs. LPNT: 7.4 ) |
LPNT'
s 10-Year ROE (%) Range
Min: -8.6 Max: 17.4 Current: 7.4 |
| ROA (%) | 3.2 |
LPNT's ROA (%) is ranked lower than
66% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 4.60 vs. LPNT: 3.2 ) |
LPNT'
s 10-Year ROA (%) Range
Min: -1.8 Max: 9.7 Current: 3.2 |
| ROC (Joel Greenblatt) (%) | 65.60 |
LPNT's ROC (Joel Greenblatt) (%) is ranked lower than
71% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 17.40 vs. LPNT: 65.60 ) |
LPNT'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 13.3 Max: 65.6 Current: 65.6 |
| Revenue Growth (%) | 14.9 |
LPNT's Revenue Growth (%) is ranked higher than
63% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 4.50 vs. LPNT: 14.9 ) |
LPNT'
s 10-Year Revenue Growth (%) Range
Min: 4.2 Max: 16.8 Current: 14.9 |
| EBITDA Growth (%) | 43 |
LPNT's EBITDA Growth (%) is ranked higher than
79% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 4.70 vs. LPNT: 43 ) |
LPNT'
s 10-Year EBITDA Growth (%) Range
Min: 2.8 Max: 43 Current: 43 |
| EPS Growth (%) | 6 |
LPNT's EPS Growth (%) is ranked higher than
77% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 7.70 vs. LPNT: 6 ) |
LPNT'
s 10-Year EPS Growth (%) Range
Min: -4.7 Max: 34.4 Current: 6 |
| Richard Snow 22,500 sh (New) Chuck Royce 243,000 sh (New) Paul Tudor Jones 10,000 sh (+26.58%) Larry Robbins 1,449,040 sh (+15.11%) Diamond Hill Capital 581,143 sh (+0.94%) | HOTCHKIS & WILEY 1,171,000 sh (-0.08%) David Dreman 885,695 sh (-1.42%) Steven Cohen 9,948 sh (-63.32%) Jim Simons 9,830 sh (-65.06%) |
| Larry Robbins 2,402,277 sh (+65.78%) Chuck Royce 303,000 sh (+24.69%) | Richard Snow 22,500 sh (unchged) | Steven Cohen Sold Out Jim Simons Sold Out HOTCHKIS & WILEY 1,158,100 sh (-1.1%) Diamond Hill Capital 570,488 sh (-1.83%) David Dreman 865,150 sh (-2.32%) Paul Tudor Jones 9,300 sh (-7%) |
| Steven Cohen 262,256 sh (New) Paul Tudor Jones 16,900 sh (+81.72%) HOTCHKIS & WILEY 1,869,900 sh (+61.46%) Diamond Hill Capital 575,205 sh (+0.83%) | Jeremy Grantham 14,245 sh (unchged) Larry Robbins 2,402,277 sh (unchged) | Chuck Royce Sold Out Richard Snow Sold Out David Dreman 848,559 sh (-1.92%) |
| Ray Dalio 38,407 sh (New) Larry Robbins 3,620,895 sh (+50.73%) Jeremy Grantham 15,035 sh (+5.55%) | David Dreman 812,199 sh (-4.28%) Paul Tudor Jones 10,900 sh (-35.5%) Steven Cohen 133,557 sh (-49.07%) HOTCHKIS & WILEY 847,300 sh (-54.69%) Diamond Hill Capital 87,338 sh (-84.82%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| HOTCHKIS & WILEY | 2013-03-31 | Reduce -54.69% | 0.22% | $37.75 - $48.5 | $ 47.38 | 8% | 847300 | |
| Ray Dalio | 2013-03-31 | New Buy | 0.02% | $37.75 - $48.5 | $ 47.38 | 8% | 38407 | |
| HOTCHKIS & WILEY | 2012-12-31 | Add 61.46% | 0.16% | $35.19 - $43.41 | $ 47.38 | 24% | 1869900 | |
| Richard Snow | 2012-12-31 | Sold Out | 0.05% | $35.19 - $43.41 | $ 47.38 | 24% | 0 | |
| Richard Snow | 2012-06-30 | New Buy | 0.05% | $34.58 - $41.17 | $ 47.38 | 25% | 22500 | |
| Richard Snow | 2012-03-31 | Sold Out | 1.4% | $35.58 - $41.63 | $ 47.38 | 30% | 0 | |
| Joel Greenblatt | 2012-03-31 | Sold Out | 0.12% | $35.58 - $41.63 | $ 47.38 | 30% | 0 | |
| HOTCHKIS & WILEY | 2012-03-31 | Add 43.05% | 0.08% | $35.58 - $41.63 | $ 47.38 | 30% | 1171900 | |
| Richard Snow | 2011-12-31 | Reduce -50.76% | 1.5% | $33.44 - $40.34 | $ 47.38 | 26% | 762551 | |
| Joel Greenblatt | 2011-12-31 | New Buy | 0.12% | $33.44 - $40.34 | $ 47.38 | 26% | 27684 | |
| Ray Dalio | 2011-12-31 | Sold Out | 0.11% | $33.44 - $40.34 | $ 47.38 | 26% | 0 | |
| Ray Dalio | 2011-09-30 | Add 107.95% | 0.06% | $29.16 - $40.43 | $ 47.38 | 34% | 203274 | |
| George Soros | 2011-09-30 | Sold Out | 0.0325% | $29.16 - $40.43 | $ 47.38 | 33% | 0 | |
| George Soros | 2011-06-30 | Add 556.67% | 0.03% | $37.88 - $43.27 | $ 47.38 | 18% | 59100 | |
| Andreas Halvorsen | 2011-03-31 | Sold Out | 0.25% | $34.84 - $39.9 | $ 47.38 | 27% | 0 | |
| HOTCHKIS & WILEY | 2011-03-31 | Add 267.19% | 0.17% | $34.84 - $39.9 | $ 47.38 | 27% | 1074400 | |
| John Hussman | 2011-03-31 | Sold Out | $34.84 - $39.9 | $ 47.38 | 27% | 0 | ||
| Andreas Halvorsen | 2010-12-31 | New Buy | 0.25% | $33.28 - $37.575 | $ 47.38 | 33% | 823452 | |
| HOTCHKIS & WILEY | 2010-09-30 | Reduce -32.37% | 0.03% | $29.71 - $36.69 | $ 47.38 | 48% | 292600 | |
| George Soros | 2010-09-30 | Reduce -42.86% | $29.71 - $36.69 | $ 47.38 | 48% | 8000 | ||
| John Hussman | 2010-06-30 | Reduce -30.43% | 0.05% | $31.76 - $39.27 | $ 47.38 | 33% | 327000 | |
| HOTCHKIS & WILEY | 2010-06-30 | Reduce -24.34% | 0.02% | $31.76 - $39.27 | $ 47.38 | 33% | 432673 | |
| Richard Snow | 2010-03-31 | Add 34.08% | 0.66% | $29.02 - $37.91 | $ 47.38 | 46% | 1898163 | |
| George Soros | 2010-03-31 | New Buy | 0.01% | $29.02 - $37.91 | $ 47.38 | 46% | 13800 |
More recent guru trades are included for Premium Members only!!
| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 17.80 |
LPNT's P/E(ttm) is ranked higher than
75% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 16.20 vs. LPNT: 17.80 ) |
LPNT'
s 10-Year P/E(ttm) Range
Min: 8.83 Max: 92.82 Current: 17.8 |
| P/B | 1.08 |
LPNT's P/B is ranked higher than
79% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 1.99 vs. LPNT: 1.08 ) |
LPNT'
s 10-Year P/B Range
Min: 0.57 Max: 13.55 Current: 1.08 |
| P/S | 0.48 |
LPNT's P/S is ranked higher than
58% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.81 vs. LPNT: 0.48 ) |
LPNT'
s 10-Year P/S Range
Min: 0.35 Max: 2.98 Current: 0.48 |
| PFCF | 11.23 |
LPNT's PFCF is ranked lower than
55% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 14.34 vs. LPNT: 11.23 ) |
LPNT'
s 10-Year PFCF Range
Min: 6.04 Max: 87.1 Current: 11.23 |
| EV-to-EBIT | 2.43 |
LPNT's EV-to-EBIT is ranked lower than
58% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 13.20 vs. LPNT: 2.43 ) |
LPNT'
s 10-Year EV-to-EBIT Range
Min: 2.1 Max: 29.7 Current: 2.43 |
| PEG | 0.48 |
LPNT's PEG is ranked higher than
95% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 1.30 vs. LPNT: 0.48 ) |
LPNT'
s 10-Year PEG Range
Min: 0.55 Max: 2.4 Current: 0.48 |
| Shiller P/E | 16.96 |
LPNT's Shiller P/E is ranked higher than
82% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 11.50 vs. LPNT: 16.96 ) |
LPNT'
s 10-Year Shiller P/E Range
Min: 8.54 Max: 43.95 Current: 16.96 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 5.8 |
LPNT's Price/Net Current Asset Value is ranked higher than
59% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 6.55 vs. LPNT: 5.8 ) |
LPNT'
s 10-Year Price/Net Current Asset Value Range
Min: 4.8 Max: 58.3 Current: 5.8 |
| Price/Tangible Book | 6.3 |
LPNT's Price/Tangible Book is ranked higher than
85% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 2.70 vs. LPNT: 6.3 ) |
LPNT'
s 10-Year Price/Tangible Book Range
Min: 3.8 Max: 22.3 Current: 6.3 |
| Price/DCF (Projected) | 0.5 | ||
| Price/Median PS Value | 0.6 |
LPNT's Price/Median PS Value is ranked higher than
66% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.90 vs. LPNT: 0.6 ) |
LPNT'
s 10-Year Price/Median PS Value Range
Min: 0.5 Max: 3.5 Current: 0.6 |
| Price/Peter Lynch Fair Value | 1 |
LPNT's Price/Peter Lynch Fair Value is ranked lower than
71% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 1.10 vs. LPNT: 1 ) |
LPNT'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.7 Max: 2.2 Current: 1 |
| Price/Graham Number | 1.9 |
LPNT's Price/Graham Number is ranked higher than
92% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 1.30 vs. LPNT: 1.9 ) |
LPNT'
s 10-Year Price/Graham Number Range
Min: 1.6 Max: 9.6 Current: 1.9 |
| Earnings Yield (Greenblatt) | 41.20 |
LPNT's Earnings Yield (Greenblatt) is ranked higher than
54% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 8.50 vs. LPNT: 41.20 ) |
LPNT'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.4 Max: 47.6 Current: 41.2 |
| Forward Rate of Return (Yacktman) | 27.59 |
LPNT's Forward Rate of Return (Yacktman) is ranked higher than
81% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 11.99 vs. LPNT: 27.59 ) |
LPNT'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: 11.5 Max: 29.2 Current: 27.59 |
| Industry: | Medical Care | |
|---|---|---|
| Compare: | CHE, FMS, DVA, FSNUY, BDUUF | |
| Traded in other countries: | LPO.Germany |